Munster, Indiana, is a thriving suburb 30 miles south of the heart of Chicago. It’s a place where the locals like to stay local, especially when it comes to healthcare. Patients in the area often turn to 454-bed Community Hospital, one of three acute-care hospitals part of Community Healthcare System. 

Hospitals should be making every effort to help sonographers deliver better, more accurate echocardiograms and improve the diagnosis of severe aortic stenosis. If you take care of your sonographers, your sonographers will take care of you. 

“The Evolut FX system is an improvement over previous Evolut system devices and it delivers better overall results to our patients,” says interventional cardiologist Guilherme Attizzani, MD. “It is an ideal solution for a majority of our patients.”

When the time came to select new angiography equipment at Benefis Health System in Montana, Michael Eisenhauer, MD, named three attributes the new suite would have to deliver without compromise. Number 1 was image quality. Number 2 was image quality. Number 3? Say it one more time.

Dr. Kroman, DO, PhD, cardiac electrophysiologist and director of the lead management program at Medical University of South Carolina, speaks about the PaceMate system as an integral part of her device clinic and overall lead management. She expressed the benefit of using the data-rich PaceMateLIVE platform to inform her lead management and research program.

Change is on the horizon for cath labs all over the world as more and more interventional cardiologists are starting to use coronary CT angiography to plan and guide PCI procedures. Patients, physicians, catheterization labs and healthcare systems all stand to gain from this growing trend.

Identifying patients with severe aortic stenosis who could potentially benefit from transcatheter aortic valve replacement (TAVR) is very important—but managing and tracking them over time can be quite a challenge.

When the ACC and AHA collaborated on new valvular heart disease guidelines in 2020, the two groups highlighted the importance of interventional treatment options such as TAVR. However, an estimated one-third of patients with severe aortic stenosis in the U.S. still lack a guideline-recommended treatment plan.